Personalized Plans : Medication and monitoring tailored to your needs
Adverse effects similar to those observed in rats treated with fluoxetine during the juvenile period have not been reported after administration of fluoxetine to adult animals
The FDA issued a Drug Safety Communication in 2024 stating that their review did not find clear evidence of an increased risk of suicidal thoughts or actions with GLP-1 receptor agonists, though they continue to evaluate this safety concern
Because tirzepatide targets two incretin receptors rather than one, its weight loss trajectory tends to be steeper initially, with greater total weight loss over time compared to semaglutide monotherapy
Available Semaglutide Formulations Two primary versions of semaglutide are commonly used: Wegovy : Approved by the FDA for long-term weight management in adults with obesity or overweight individuals who have at least one weight-related condition, including PCOS
Analyst Thibault Boutherin anticipates that ziltivekimab will demonstrate a reduction in cardiovascular risk of more than 15% in the study, and based on that, he sees a potential for USD 3 billion in annual sales for the drug